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Interleukin (IL)-17 expression has been correlated with the pathogenesis of mul-
tiple autoimmune diseases, as rheumatoid arthritis, multiple sclerosis, and, more 
recently, psoriasis (1). During plaque formation, the interplay between immunocytes 
and keratinocytes is deregulated, resulting in the altered expression of keratin (K) 17, 
occludin, and filaggrin in psoriatic lesional epidermis (2, 3). The involvement of IL-17 
in psoriasis pathogenesis has been identified (4), but the specific and intrinsic effects 
exerted by this cytokine have not been thoroughly investigated. The aim of the pre-
sent work was to study by indirect immunofluorescence the expressions of K17, K10, 
filaggrin, and occludin in a three-dimensional model of normal human skin stand-
ardized in our laboratory (5). Human skin samples (n = 5) obtained from healthy 
20-40 years-old women after plastic surgery, were exposed to IL-17 in a Transwell 
system at air-liquid interface as previously described (5). Samples were harvested 24 
(T24), 48 (T48), and 72 (T72) hours after IL-17 stimulation and processed for paraffin 
embedding and immunofluorescence analysis for expressions of K17, K10, filaggrin, 
and occludin. After IL-17 exposition, K17 immunostaining progressively increased 
with time in the upper stratum spinosum, while K10 expression resulted homogene-
ously distributed in the suprabasal layers. In IL-17 treated samples occludin staining 
became irregular starting from 24 hours. On the other hand, filaggrin distribution 
was affected in T48 samples, where the immunolabelling was discontinuously punc-
tuate. In conclusion, our results strongly support the use of this experimental setting 
for investigating the time-dependent early effects induced by IL-17 in normal human 
skin. 
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